Login to Your Account



2,242 Trial Deaths, Few Rules: India Aims for Regulatory Reform

By Randy Osborne
Staff Writer

Wednesday, March 20, 2013
India's Drug and Cosmetics Act purports to keep clinical trials kosher under something called Schedule Y, but the law – which has not been amended since 2005 – lacks rules for mandatory practice and does not specify what recourse trial participants have when things go wrong.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription